Microbot Medical (MBOT) Enterprise Value (2010 - 2026)

Microbot Medical has reported Enterprise Value for 17 years, with the latest figure at -$69.6 million in Q1 2026.

• For the quarter ending Q1 2026, Enterprise Value fell 155.86% year-over-year to -$69.6 million; the trailing twelve-month figure through Mar 2026 stood at -$69.6 million (down 155.86% YoY), and the FY2025 full-year result was -$78.6 million, down 1336.78% from the prior year.
• Enterprise Value for Q1 2026 stood at -$69.6 million, up from -$78.6 million in the prior quarter.
• The five-year high for Enterprise Value was -$2.1 million in Q3 2022, with the low at -$80.2 million in Q3 2025.
• Historically, Enterprise Value has averaged -$20.3 million across 5 years, with a median of -$6.4 million in 2023.
• Annual changes were most pronounced in 2022 — Enterprise Value surged 90.91% — and 2025, when it sank 1747.81%.
• Microbot Medical's Enterprise Value stood at -$2.4 million in 2022, then tumbled by 161.15% to -$6.4 million in 2023, then increased by 14.33% to -$5.5 million in 2024, then sank by 1336.78% to -$78.6 million in 2025, then climbed by 11.38% to -$69.6 million in 2026.
• The last three Enterprise Value figures came in at -$69.6 million (Q1 2026), -$78.6 million (Q4 2025), and -$80.2 million (Q3 2025), per Business Quant data.